Precipio Inc. (PRPO)
6.73
0.35 (5.49%)
At close: Jan 28, 2025, 12:49 PM
Company Description
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States.
It provides diagnostic blood cancer testing services.
The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; ICE-COLD PCR, a proprietary and patented specimen technology that increases the sensitivity of molecular based tests; and COVID-19 antibody tests.
It sells ICE-COLD-PCR technology kits to bio-pharma customers.
Precipio, Inc. has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment.
The company is based in New Haven, Connecticut.
Precipio Inc.
| Country | United States |
| IPO Date | Jun 30, 2017 |
| Industry | Medical - Diagnostics & Research |
| Sector | Healthcare |
| Employees | 51 |
| CEO | Ilan Danieli |
Contact Details
Address: 4 Science Park New Haven, Connecticut United States | |
| Website | https://www.precipiodx.com |
Stock Details
| Ticker Symbol | PRPO |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001043961 |
| CUSIP Number | 74019L503 |
| ISIN Number | US74019L6020 |
| Employer ID | 91-1789357 |
| SIC Code | 3826 |
Key Executives
| Name | Position |
|---|---|
| Ilan Danieli | Founder, President, Chief Executive Officer & Director |
| Ahmed Zaki Sabet | Chief Operating Officer |
| Dr. Ayman A. Mohamed M.D. | Chief Technology Officer |
| Matthew Gage | Chief Financial Officer |
| Miri Chiko-Radomski | Chief Legal Counsel & People Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jan 21, 2025 | 8-K | Current Report |
| Jan 16, 2025 | 4 | Filing |
| Jan 16, 2025 | 4 | Filing |
| Jan 16, 2025 | 4 | Filing |
| Jan 16, 2025 | 4 | Filing |
| Jan 16, 2025 | 4 | Filing |
| Jan 16, 2025 | 4 | Filing |
| Jan 16, 2025 | 4 | Filing |
| Jan 16, 2025 | 4 | Filing |
| Jan 16, 2025 | 4 | Filing |